First Time Loading...

Rosetta Genomics Ltd
OTC:ROSGQ

Watchlist Manager
Rosetta Genomics Ltd Logo
Rosetta Genomics Ltd
OTC:ROSGQ
Watchlist
Price: 0.0001 USD Market Closed
Updated: May 16, 2024

Balance Sheet

Balance Sheet Decomposition
Rosetta Genomics Ltd

Current Assets 5.7m
Cash & Short-Term Investments 1.3m
Receivables 987k
Other Current Assets 3.4m
Non-Current Assets 527k
PP&E 522k
Other Non-Current Assets 5k
Current Liabilities 2.7m
Accounts Payable 2m
Other Current Liabilities 713k
Non-Current Liabilities 2.4m
Long-Term Debt 37k
Other Non-Current Liabilities 2.4m

Balance Sheet
Rosetta Genomics Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016
Assets
Cash & Cash Equivalents
14
14
3
3
1
31
17
8
12
6
Cash Equivalents
14
14
3
3
1
31
17
8
12
6
Short-Term Investments
8
1
6
1
0
0
8
8
0
0
Total Receivables
0
1
0
0
0
1
0
1
6
3
Accounts Receivables
0
1
0
0
0
0
0
0
4
3
Other Receivables
0
0
0
0
0
1
0
0
2
0
Other Current Assets
0
0
1
0
0
0
0
0
1
0
Total Current Assets
22
17
11
4
1
32
25
16
19
10
PP&E Net
1
1
1
1
1
1
1
1
3
2
PP&E Gross
1
1
1
1
1
1
1
1
3
2
Accumulated Depreciation
1
1
1
2
2
2
2
2
3
4
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Goodwill
0
2
0
0
0
0
0
0
0
0
Note Receivable
0
0
1
0
0
0
0
0
0
0
Long-Term Investments
2
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Other Assets
0
2
0
0
0
0
0
0
0
0
Total Assets
26
N/A
20
-23%
13
-37%
5
-58%
2
-61%
33
+1 491%
26
-20%
17
-33%
22
+30%
12
-47%
Liabilities
Accounts Payable
1
1
1
2
1
1
1
1
1
2
Accrued Liabilities
1
1
1
1
1
1
1
2
2
2
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
2
3
2
3
2
1
2
2
3
4
Long-Term Debt
0
1
2
1
0
0
0
0
0
0
Minority Interest
0
0
0
1
0
0
0
0
0
0
Other Liabilities
1
1
2
1
0
0
0
0
0
4
Total Liabilities
2
N/A
4
+67%
6
+46%
7
+14%
2
-64%
2
-32%
2
+38%
2
-2%
3
+27%
8
+169%
Equity
Common Stock
0
0
0
0
0
1
2
2
3
3
Retained Earnings
35
45
61
76
85
96
108
123
140
157
Additional Paid In Capital
59
61
68
75
85
125
130
136
157
157
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
24
N/A
16
-32%
7
-58%
1
N/A
0
+75%
31
N/A
24
-24%
15
-36%
20
+30%
4
-77%
Total Liabilities & Equity
26
N/A
20
-23%
13
-37%
5
-58%
2
-61%
33
+1 491%
26
-20%
17
-33%
22
+30%
12
-47%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
1
1
1
2
2

See Also

Discover More